The structure differences of Japanese encephalitis virus SA14 and SA14-14-2 E proteins elucidate the virulence attenuation mechanism

References

[1] Aihara S, Rao CM, Yu YX, Lee T, Watanabe K, Komiya T, Sumiyoshi H, Hashimoto H, Nomoto A (1991) Identification of mutations that occurred on the genome of Japanese encephalitis virus during the attenuation process. Virus Genes 5(2):95–109

[2] Bressanelli S, Stiasny K, Allison SL, Stura EA, Duquerroy S, Lescar J, Heinz FX, Rey FA (2004) Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation. EMBO J 23(4):728–738

[3] Harrison SC (2015) Viral membrane fusion. Virology 479– 480:498–507

[4] Huang CY, Butrapet S, Moss KJ, Childers T, Erb SM, Calvert AE, Silengo SJ, Kinney RM, Blair CD, Roehrig JT (2010) The dengue virus type 2 envelope protein fusion peptide is essential for membrane fusion. Virology 396(2):305–315

[5] Luca VC, AbiMansour J, Nelson CA, Fremont DH (2012) Crystal structure of the Japanese encephalitis virus envelope protein. J Virol 86(4):2337–2346

[6] Modis Y, Ogata S, Clements D,Harrison SC (2003) A ligand-binding pocket in the dengue virus envelope glycoprotein. Proc Natl Acad Sci USA 100(12):6986–6991

[7] Modis Y, Ogata S, Clements D, Harrison SC (2004) Structure of the dengue virus envelope protein after membrane fusion. Nature 427(6972):313–319

[8] Mukhopadhyay S, Kuhn RJ, Rossmann MG (2005) A structural perspective of the flavivirus life cycle. Nat Rev Microbiol 3(1):13–22

[9] Wang X, Li SH, Zhu L, Nian QG, Yuan S, Gao Q, Hu Z, Ye Q, Li XF, Xie DY (2017) Near-atomic structure of Japanese encephalitis virus reveals critical determinants of virulence and stability. Nat Commun 8(1):14

[10] WHO: Japanese encephalitis. 2015, Fact sheet No 386

[11] Yang D, Li XF, Ye Q, Wang HJ, Deng YQ, Zhu SY, Zhang Y, Li SH, Qin CF (2014) Characterization of live-attenuated Japanese encephalitis vaccine virus SA14-14-2. Vaccine 32(23):2675–2681

[12] Yang J, Yang H, Li Z, Wang W, Lin H, Liu L, Ni Q, Liu X, Zeng X, Wu Y (2017) Envelope protein mutations L107F and E138K are important for neurovirulence attenuation for Japanese encephalitis virus SA14-14-2 strain. Viruses. https://doi.org/10.3390/v9010020

[13] Yu Y (2010) Phenotypic and genotypic characteristics of Japanese encephalitis attenuated live vaccine virus SA14-14-2 and their stabilities. Vaccine 28(21):3635–3641

[14] Zhang Y, Zhang W, Ogata S, Clements D, Strauss JH, Baker TS, Kuhn RJ, Rossmann MG (2004) Conformational changes of the flavivirus E glycoprotein. Structure (London, England: 1993) 12 (9):1607–1618

[15] Zhang S, Li L, Woodson SE, Huang CY, Kinney RM, Barrett AD, Beasley DW (2006) A mutation in the envelope protein fusion loop attenuates mouse neuroinvasiveness of the NY99 strain of West Nile virus. Virology 353(1):35–40

RIGHTS & PERMISSIONS

2018 The Author(s) 2018